#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metachromatic leukodystrophy Breast cancer Acquired ATTR amyloidosis Cystic fibrosis Metastatic malignant melanoma Waldenstrom's macroglobulinaemia refractory Epilepsy Pleural mesothelioma malignant Oesophageal adenocarcinoma stage II Obliterative bronchiolitis Brain abscess Bulbospinal muscular atrophy congenital Metabolic disorder Pemphigus Oesophageal carcinoma More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Life with Disease Glomerulonephritis rapidly progressive – Basic Information Synovial sarcoma recurrent – Life with Disease Breast angiosarcoma metastatic – Life with Disease Haemophilia B without inhibitors – Basic Information Haemophilia B without inhibitors Stevens-Johnson syndrome – Treatment Vascular malformation Haemophilia B without inhibitors – Treatment Osteosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    (-)-PHENSERINE TARTRATE L-Tryptophan Absk021 Hydrochloride Hydrate Botulinum Toxin Type A Clodronate Disodium Lt3001 Hydroxychloroquine Sulfate Gallium Citrate Ga-68 Midomafetamine Hydrochloride Lactose Fulvestrant Daplusiran Adct-402 Clobetasol Propionate Delafloxacin Perampanel Bms-986408 Cefuroxime Axetil ABBV-8736 Benzalkonium Chloride More therapies…

    Learn about Your Condition

    Haemolytic uraemic syndrome Mucous membrane pemphigoid Spinal osteoarthritis Follicular lymphoma Vertebrobasilar stroke Fungal infection Bladder cancer stage II Endocarditis bacterial Cervical dysplasia Splenic marginal zone lymphoma Diabetic nephropathy Postoperative wound infection Breast cancer Myelodysplastic syndrome Persistent depressive disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cholangiocarcinoma

  • Study of Tucatinib and Trastuzumab for Patients with Advanced Solid Tumors with HER2 Changes

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Tucatinib
    • Fulvestrant
    • Trastuzumab
    Belgium Germany Spain

  • Study of Durvalumab with Gemcitabine and Cisplatin for Patients with Advanced Biliary Tract Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Cisplatin
    • Durvalumab
    • Gemcitabine
    Bulgaria France Italy Poland

  • Study of Futibatinib for Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Futibatinib
    Italy Poland Portugal Spain

  • Study of Durvalumab and Tremelimumab with Y-90 SIRT Therapy for Patients with Advanced Intrahepatic Biliary Tract Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Tremelimumab
    • Durvalumab
    Germany Spain

  • Study on the Effectiveness and Safety of Gemcitabine, Cisplatin, Trastuzumab, and Pembrolizumab for Untreated HER2-Positive Biliary Tract Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gallbladder cancer
    • Cholangiocarcinoma
    Investigated Drugs:
    • Cisplatin
    • Gemcitabine Hydrochloride
    • Pembrolizumab
    Germany

  • Study on the Effects of Volrustomig and Drug Combination for Patients with Advanced Hepatobiliary Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Bile duct cancer
    • Gallbladder cancer
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Volrustomig
    • Bevacizumab
    • Rilvegostomig
    Italy Spain
Previous Page
1 … 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!